HENRY MARTINEZ: Open Payments
NPI 1417937053 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 16 payments from 8 companies in 2025. Trend: 2023 $626 · 2024 $321 · 2025 $408
Food & beverage: $408
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 4 | $163 |
| GENZYME CORPORATION | 3 | $59 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| Blueprint Medicines Corporation | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Organon LLC | 1 | $14 |
Products named: Tecentriq, DUPIXENT, NUCALA, Xolair, Rhapsido, AYVAKIT, TEZSPIRE.
Industry payments across TX — which companies pay providers there.
